A carregar...

Does safety make a difference in selecting the right TNF antagonist?

Tumor necrosis factor (TNF) antagonists are biologic response modifiers that have significantly improved the outcomes in patients with rheumatoid arthritis (RA). At this report, safety data were collected on approximately 271,000 patients administered infliximab (as of February 2002), 121,000 patien...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Fleischmann, Roy, Yocum, David
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2004
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2833460/
https://ncbi.nlm.nih.gov/pubmed/15228616
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/ar995
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!